Exact Sciences Corp (EXAS) Posts Q2 Loss of 13c/Sh., Wider than Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
Tweet
Share
E-mailGet Alerts EXAS Hot Sheet
Join SI Premium – FREE
Exact Sciences Corp (NASDAQ: EXAS) reported Q2 loss of ($0.13), $0.03 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $1 million versus the consensus estimate of $1.02 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Integra LifeSciences (IART) Tops Q3 EPS by 3c; offers guidance
- First Bancorp (FNLC) Tops Q3 EPS by 95c
- Rollins falls 7% on third quarter earnings and revenue miss
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
